| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.0029 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |
| mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |